In January 2017, Merial became a part of Boehringer Ingelheim. As the second largest veterinary business in the world, Boehringer Ingelheim seeks to develop the industry in the interest of improving animal health.

Boehringer Ingelheim is one of the 20 leading pharmaceutical companies in the world that develops and manufactures original medicines for the prevention and treatment of various diseases, veterinary drugs and biotechnological products.

In Russia, dozens of veterinary products are registered and sold, including 10 of the most important pharmaceuticals for the swine industry.
Intensive research and modern technology is the foundation of the Boehringer Ingelheim Veterinary business unit. Scientists of international research centers work on innovative solutions to provide the best care to animals.

The researchers are aimed to identify modern and innovative solutions to the most complicated veterinary problems. Increased globalization as well as processes related with climatic changes can lead to appearance of new diseases, therefore the timely creation of medicines for their treatment is a key factor in protecting animal and human health.